Cultural barriers to initiating insulin therapy in Chinese people with type 2 diabetes living in Canada

Canadian Journal of Diabetes

Volumn 30, Issue 4, 2006, Pages 390-396

  Ho, Edith Y ^a,c   James, Jacqueline ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Leadership Sinai Centre for Diabetes   (Canada)

Author keywords

Chinese Canadians; Cultural barriers; Health attitudes; Insulin; Treatment refusal

Indexed keywords

ACETYLSALICYLIC ACID; CHINESE DRUG; CINNAMON EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; INSULIN;

ACUPUNCTURE; ADULT; AGED; ARTICLE; CANADA; CHINESE; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; DIABETES EDUCATION; DIABETES MELLITUS; DIET; DRUG COST; ETHNIC DIFFERENCE; FEMALE; FENUGREEK; FUNGUS; HEALTH CARE COST; HUMAN; INSULIN TREATMENT; MALE; MASSAGE; MEDICINAL PLANT; MOMORDICA CHARANTIA; MUSHROOM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; SOYBEAN; STIGMA;

EID: 33845603494     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(06)04004-4     Document Type: Article

References (18)

1. Canadian Diabetes Association. The prevalence and costs of diabetes. Available at: http://www.diabetes.ca/Section_about/prevalence.asp. Accessed December 15, 2006.
2. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249-1258.
3. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24.
4. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care. 1997;20:292-298.
5. Shah CP. Public Health and Preventive Medicine in Canada. 5th ed. Toronto, ON: Saunders; 2003.
6. O'Loughlin J. Understanding the role of ethnicity in chronic disease: a challenge for the new millennium. CMAJ. 1999;161:152-153.
7. Haley L. Consider patient's ethnicity when treating diabetes. Can Diabetes Med Post. 2002;38:38.
8. Harris MI, Eastman RC, Cowie CC, et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999;22:403-408.
9. Chaturvedi N, Fuller JH. Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes? J Epidemiol Community Health. 1996;50:137-139.
10. Reddy KS. Ethnic diversity: the new challenge of preventive cardiology. J Int Soc Fed Cardiol. 1998;1:6-8.
11. Ratzmann KP. The psychological aspects of diabetics with the secondary failure of sulfonylurea therapy. Dtsch Med Wochenschr. 1991;116:87-90.
12. Wolffenbuttel BH, Drossaert CH, Visser AP. Determinants of injecting insulin in elderly patients with type II diabetes mellittus. Patient Educ Couns. 1993;22:117-125.
13. Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient: overcoming obstacles to success. Postgrad Med. 1995;97:86-90, 93-96.
14. Miller F. When the client says 'no way' to insulin therapy. Diabetes Educ. 1995;21:187.
15. Weedon L, Curry M. Diabetes. Switching to insulin. Nurs Times. 1992;88:34-36.
16. Statistics Canada. 2001 Census of Canada. Available at: http://www12.statcan.ca/english/census01/home/index.cfm. December 15, 2006.
17. Chan JC, Cockram CS. Diabetes in the Chinese population and its implications for health care. Diabetes Care. 1997;20:1785-1790.
18. Richie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, eds. Analysing Qualitative Data. London, UK: Routledge; 1995:173-194.